Publication | Closed Access
Pharmacokinetics of bleomycin after im administration in man.
26
Citations
0
References
1981
Year
Lymphoid NeoplasiaUrologyOncologyPharmacokinetic ModelingIm InjectionPhysiologically-based Pharmacokinetic ModelingPharmacologyIm AdministrationPharmacotherapyMedicineMalignant LymphomaPharmacokineticsMean Half-life
The pharmacokinetics of bleomycin were studied after im injection in patients with malignant lymphoma. Mean peak serum concentrations of 0.133, 0.326, and 0.587 milliunits/ml were obtained approximately 1 hour after injection of 2, 5, and 10 units/m2, respectively. The mean half-life was 155 minutes, with a range of 65--235 minutes. Thirty-three percent of the administered dose was recovered in the urine after 4 hours. The urinary excretion of bleomycin was 61% during the 24 hours after injection, with some variability that was not explained by differences in dose or creatinine clearance.